Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 2
2012 6
2013 3
2014 4
2015 4
2016 1
2017 4
2018 4
2019 1
2020 3
2021 6
2022 5
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Osteoarticular Mycoses.
Gamaletsou MN, Rammaert B, Brause B, Bueno MA, Dadwal SS, Henry MW, Katragkou A, Kontoyiannis DP, McCarthy MW, Miller AO, Moriyama B, Pana ZD, Petraitiene R, Petraitis V, Roilides E, Sarkis JP, Simitsopoulou M, Sipsas NV, Taj-Aldeen SJ, Zeller V, Lortholary O, Walsh TJ; International Consortium for Osteoarticular Mycoses. Gamaletsou MN, et al. Clin Microbiol Rev. 2022 Dec 21;35(4):e0008619. doi: 10.1128/cmr.00086-19. Epub 2022 Nov 30. Clin Microbiol Rev. 2022. PMID: 36448782 Free PMC article. Review.
Therapy of Mucormycosis.
Sipsas NV, Gamaletsou MN, Anastasopoulou A, Kontoyiannis DP. Sipsas NV, et al. Among authors: gamaletsou mn. J Fungi (Basel). 2018 Jul 31;4(3):90. doi: 10.3390/jof4030090. J Fungi (Basel). 2018. PMID: 30065232 Free PMC article. Review.
Rhino-orbital-cerebral mucormycosis.
Gamaletsou MN, Sipsas NV, Roilides E, Walsh TJ. Gamaletsou MN, et al. Curr Infect Dis Rep. 2012 Aug;14(4):423-34. doi: 10.1007/s11908-012-0272-6. Curr Infect Dis Rep. 2012. PMID: 22684277
Management of osteoarticular fungal infections in the setting of immunodeficiency.
Papachristou SG, Iosifidis E, Sipsas NV, Gamaletsou MN, Walsh TJ, Roilides E. Papachristou SG, et al. Among authors: gamaletsou mn. Expert Rev Anti Infect Ther. 2020 May;18(5):461-474. doi: 10.1080/14787210.2020.1748499. Epub 2020 Apr 2. Expert Rev Anti Infect Ther. 2020. PMID: 32213145 Review.
Is Sjögren's syndrome a retroviral disease?
Sipsas NV, Gamaletsou MN, Moutsopoulos HM. Sipsas NV, et al. Among authors: gamaletsou mn. Arthritis Res Ther. 2011 Apr 13;13(2):212. doi: 10.1186/ar3262. Arthritis Res Ther. 2011. PMID: 21489323 Free PMC article. Review.
Treatment of fungal disease in the setting of neutropenia.
Walsh TJ, Gamaletsou MN. Walsh TJ, et al. Among authors: gamaletsou mn. Hematology Am Soc Hematol Educ Program. 2013;2013:423-7. doi: 10.1182/asheducation-2013.1.423. Hematology Am Soc Hematol Educ Program. 2013. PMID: 24319214 Review.
Early 3‑day course of remdesivir for the prevention of the progression to severe COVID‑19 in the elderly: A single‑centre, real‑life cohort study.
Georgakopoulou VE, Gkoufa A, Makrodimitri S, Basoulis D, Tsakanikas A, Karamanakos G, Mastrogianni E, Voutsinas PM, Spandidos DA, Papageorgiou CV, Gamaletsou MN, Sipsas NV. Georgakopoulou VE, et al. Among authors: gamaletsou mn. Exp Ther Med. 2023 Aug 9;26(4):462. doi: 10.3892/etm.2023.12161. eCollection 2023 Oct. Exp Ther Med. 2023. PMID: 37664680 Free PMC article.
Effectiveness of Oral Nirmatrelvir/Ritonavir vs. Intravenous Three-Day Remdesivir in Preventing Progression to Severe COVID-19: A Single-Center, Prospective, Comparative, Real-Life Study.
Basoulis D, Tsakanikas A, Gkoufa A, Bitsani A, Karamanakos G, Mastrogianni E, Georgakopoulou VE, Makrodimitri S, Voutsinas PM, Lamprou P, Kontos A, Tsiakas S, Gamaletsou MN, Marinaki S, Sipsas NV. Basoulis D, et al. Among authors: gamaletsou mn. Viruses. 2023 Jul 7;15(7):1515. doi: 10.3390/v15071515. Viruses. 2023. PMID: 37515201 Free PMC article.
42 results